T-cell Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for T-cell Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-09-04Clinical Trial Update: Radiolabeled Monoclonal Antibody and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With High-Risk Lymphoid Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating a radiolabeled monoclonal antibody with combination chemotherapy before stem cell transplant in high-ris…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors [Phase 1]
This clinical trial update reports the completion of a Phase 1 study of CB-839 (telaglenastat), a glutaminase inhibitor, in hematological tu…
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating bortezomib plus vorinostat as maintenance after autologous stem cell transplant in non-Hodgkin lymphoma showed resu…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma [Phase 2]
Phase 2 trial investigating CHOEP plus high-dose therapy and autologous stem cell transplant for T-cell non-Hodgkin lymphoma was terminated …
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: Gleevec in Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma [Phase 2]
A phase 2 trial of Gleevec (imatinib) in relapsed/refractory T-cell non-Hodgkin lymphoma has completed enrollment and posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2016-12-15Clinical Trial Update: Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin Lymphoma [NA]
A clinical trial evaluating denileukin diftitox in combination with chemotherapy for newly diagnosed T-cell non-Hodgkin lymphoma has been wi…
-
CLINICAL_TRIALS research · 2016-12-08Clinical Trial Update: Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating chidamide with CHOEP chemotherapy and upfront autologous stem cell transplant in untreated peripheral …
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma [Phase 2]
This report covers the completion of a Phase II clinical trial evaluating lenalidomide for T-cell non-Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
A Phase 1/2 study evaluated vorinostat (SAHA) in combination with CHOP chemotherapy in patients with untreated T-cell non-Hodgkin's lymphoma…
-
CLINICAL_TRIALS research · 2013-09-20Clinical Trial Update: Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
This clinical trial investigates the use of alemtuzumab in combination chemotherapy for newly diagnosed stage II, stage III, or stage IV T-c…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction [Phase 1]
This clinical trial update summarizes a Phase 1 study of Imatinib Mesylate in patients with advanced cancer and liver dysfunction, which has…
-
CLINICAL_TRIALS research · 2012-10-24Clinical Trial Update: Pharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma. [Phase 1, Phase 2]
Terminated Phase 1/2 pharmacokinetic study of forodesine in children with relapsed or refractory T-cell or B-cell precursor acute lymphoblas…
-
CLINICAL_TRIALS trial_result · 2012-07-09Clinical Trial Update: Clofarabine for Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin Lymphoma (NHL) [Phase 1, Phase 2]
This update summarizes Phase 1/2 trial results for clo farabine in relapsed or refractory T-cell or B-cell non-Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2012-01-05Clinical Trial Update: A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refractory T-Cell Non-Hodgkin's Lymphoma [Phase 2]
Phase II study of single-agent lenalidomide in relapsed or refractory T-cell non-Hodgkin's lymphoma has been terminated; results posted in 2…
-
CLINICAL_TRIALS trial_result · 2010-07-09Clinical Trial Update: Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating the combination of vorinostat and bortezomib in relapsed or refractory T-cell non-Hodgkin lymphoma was terminated; …